Following pre-treatment with cyclophosphamide and/or fludarabine, NY-ESO-1-specific TCR gene
transduced T lymphocytes are transferred to the patients with NY-ESO-1-expressing solid
tumors.
Phase:
Phase 1
Details
Lead Sponsor:
Mie University
Collaborators:
Fiverings Co., Ltd. Shionogi Statcom Co. Ltd. Takara Bio Inc.